Evidence map›Paper›PMID 31312857›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2019

MiR-138-5p exacerbates hypoxia/reperfusion-induced heart injury through the inactivation of SIRT1-PGC-1α.

Cuiping Wang, Xia Sun, Zhi Qiu, Anyong Chen

RetractedAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. The extract fromHeliyon · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Retraction Note to: MiR-138-5p exacerbates hypoxia/reperfusion-induced heart injury through the inactivation of SIRT1-PGC-1α.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2020
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Cuiping WangDepartment of Cardiology, Affiliated Hospital of Jining Medical University, Jining, 272000, Shandong, People's Republic of China.
Xia SunDepartment of Cardiology, Affiliated Hospital of Jining Medical University, Jining, 272000, Shandong, People's Republic of China.
Zhi QiuDepartment of Cardiology, Affiliated Hospital of Jining Medical University, Jining, 272000, Shandong, People's Republic of China.
Anyong ChenDepartment of Cardiology, Affiliated Hospital of Jining Medical University, Jining, 272000, Shandong, People's Republic of China. jyfywcp@163.com.
Affiliated Hospital of Jining Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesA drastic reduction in myocardial cell apoptosis plays a crucial role in the treatment/management of myocardial infarction, a major cardiovascular health challenge confronting the world, especially the Western world. Accumulating evidence indicates that the cardiotoxicity caused by the apoptotic machinery is partly regulated by miRNAs. The aim of this research is to investigate the role of miR-138-5p on hypoxia/reperfusion-induced heart injury.

methodsThe expression of miR-138-5p was determined in heart tissue from myocardial infarction patients and rats. Rats were transfection with a miR-138-5p inhibitor to silence miR-138-5p. The cardiac function of rats was detected via echocardiography. SIRT1 and PGC-1α expression in cardiac infarction was detected via quantitative Real-time PCR (qPCR) and Western blot analysis, while the TUNEL assay was used to determine myocardial apoptosis.

resultsOur observations showed that miR-138-5p expression was upregulated after the induction of myocardial infarction. The miR-138-5p inhibitor significantly improved cardiac function, increased the expression of SIRT1 and PGC-1α, and decreased the rate of myocardial apoptosis, whereas siRNA-SIRT1 reversed these protective effects.

conclusionsIn conclusion, our study demonstrated that miR-138-5p could promote cardiac ischemia injury via inhibition of the silent information regulator 1 and peroxisome proliferator-initiated receptor gamma and coactivator 1 alpha (SIRT1-PGC-1α) axis.

Indexed as

HypoxiaMicroRNAsMyocardial Reperfusion InjuryAnimalsHEK293 CellsHumansMyocardiumPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaRats, Sprague-DawleySirtuin 1Ventricular Function, LeftMicroRNAsMIRN138 microRNA, humanMIRN138 microRNA, ratPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, ratSirt1 protein, ratSirtuin 1CardiacHypoxia/ischemiamiR-138-5pPGC-1αSIRT1

Identifiers

PMID31312857
OpenAlexW2959264642

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.